Introducing Mifepristone-Misoprostol for Menstrual Regulation in Public Sector Facilities in Bangladesh
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
This open-label study is being conducted to determine whether a mifepristone-misoprostol
regimen for uterine evacuation which consists of 200 mg mifepristone followed 24 hours later
by 800 mcg buccal misoprostol is acceptable to women and providers and feasible for
introduction in public sector facilities in Bangladesh. It will also determine the
feasibility of women availing the option of taking their dose of misoprostol outside the
facility.